Find out how we provide timely and effective services!
Bonteque Consulting Ltd is a qualified company that
develops the product cytisinicline supporting
the fight against nicotine addiction.
Cytisinicline called also as cytisine is a very common
substance that combats "nicotine craving". This compound
is an organic compound found in some plant species. It is used in the fight against nicotine addiction. The designated goal is to reach the largest group of smokers with the aim of solving nicotine starvation, as it has become a global problem of the 21st century.
Bonteque Consulting Ltd is a company whose goal is to reduce mortality among smokers, as well as to reduce the occurrence of diseases that cause damage to human health. The company wants to reach the largest group of people, is still looking for new ways to reach addicts. According to statistics, in order to quit smoking, cytisine was used by over 20 million people, including 2.000 people taking part in ongoing clinical trials of the penultimate phase.
Sign up to hear from us.
We invest in the development of innovative medicinal products. We focus mainly on generic medicinal products thanks to which we can provide a wide range of patients with access to modern therapies. At the same time we conduct our own research and development activities.
Adverse Events Reporting
If you want to report an Adverse Event, please contact us directly or fill enclosed above form and send it to:
e-mail: drugsafety@consilienthealth.com
you can also call:
24 h Phone: (+44) 020 3751 1888
Business matters contact: Bonteque Consulting Ltd.
Phone: (+44) 075 6673 6069
e-mail: director@bonteque.co.uk
29 Westcott Crescent, Hanwell, W7 1PL London, United Kingdom
Business matters hours
Monday - Friday: 9:00 am - 5:00 pm
Saturday - Sunday: Closed
29 Westcott Crescent, Hanwell, W7 1PL London, United Kingdom
Copyright © 2018 Bonteque Ltd - All Rights Reserved.
Powered by GoDaddy